Canada backs reimbursement for Kisunla; Lilly faces a 340B data lawsuit and Missouri order while guiding 2026 revenue to ...

After a 57% run-up over the past 52 weeks, Eli Lilly (NYSE: LLY) shares are expensive. The stock is now trading at 47 times trailing earnings. That's more than double the price-to-earnings ratio of ...

The case is the latest in a series of challenges that Lilly and Novo have brought against companies providing compounded ...

Some of Eli Lilly’s products beyond its core therapeutic area are performing well. It also boasts a deep and diversified ...

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier ...

NOTE: Figures on this page are calculations by OpenSecrets based on data from the Senate Office of Public Records. Data for the most recent year was downloaded on July 23, 2026 and includes spending ...

The Eli Lilly and Co. manufacturing site being built in Goochland County might be the largest economic development project in the county's history, local leaders said. For comparison, Lilly's $5 ...

Industry sources tell Sports Business Journal that Excel has snared the AOR assignment both for mega-pharma Eli Lilly (2025 ...

Eli Lilly’s revenue surged on strong tirzepatide demand, but pricing and patent risks loom. Click here to read an analysis of ...

Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that ...